Individual and small-group market health insurance rate review and disclosure: state and federal roles after PPACA.

Kathryn Linehan
{"title":"Individual and small-group market health insurance rate review and disclosure: state and federal roles after PPACA.","authors":"Kathryn Linehan","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Oversight of private insurance, including health insurance, is primarily a state responsibility. Each state establishes its own laws and regulations regarding insurer activities, including premium increases for the insurance products within its purview. The authority that state regulators have to review and deny requests for premium changes varies from state to state, as do the amount of resources available to state insurance departments for reviewing premium changes. In some markets where insurers have proposed or implemented steep increases, such changes have received considerable attention from the press, state regulators, and policymakers. The Patient Protection and Affordable Care Act (PPACA) requires annual review of premium increases and disclosure of those increases determined unreasonable beginning in September 2011. Under PPACA, each state will conduct these reviews for individual and small-group health insurance unless the federal government concludes they do not have an effective review program and assumes review responsibility. As they did prior to PPACA, state laws govern whether rates go into effect and establish the parameters of regulators' authority. This issue brief outlines specific state and federal roles in the rate review process and changes to rate review processes since PPACA was enacted.</p>","PeriodicalId":87188,"journal":{"name":"Issue brief (George Washington University. National Health Policy Forum : 2005)","volume":" 844","pages":"1-13"},"PeriodicalIF":0.0000,"publicationDate":"2011-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Issue brief (George Washington University. National Health Policy Forum : 2005)","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Oversight of private insurance, including health insurance, is primarily a state responsibility. Each state establishes its own laws and regulations regarding insurer activities, including premium increases for the insurance products within its purview. The authority that state regulators have to review and deny requests for premium changes varies from state to state, as do the amount of resources available to state insurance departments for reviewing premium changes. In some markets where insurers have proposed or implemented steep increases, such changes have received considerable attention from the press, state regulators, and policymakers. The Patient Protection and Affordable Care Act (PPACA) requires annual review of premium increases and disclosure of those increases determined unreasonable beginning in September 2011. Under PPACA, each state will conduct these reviews for individual and small-group health insurance unless the federal government concludes they do not have an effective review program and assumes review responsibility. As they did prior to PPACA, state laws govern whether rates go into effect and establish the parameters of regulators' authority. This issue brief outlines specific state and federal roles in the rate review process and changes to rate review processes since PPACA was enacted.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
个人和小团体市场健康保险费率审查和披露:PPACA后州和联邦的角色。
监督私人保险,包括医疗保险,主要是国家的责任。各州就保险公司的活动制定了自己的法律法规,包括其管辖范围内保险产品的保费增加。州监管机构审查和拒绝保费变更请求的权力因州而异,州保险部门用于审查保费变更的可用资源数量也各不相同。在一些保险公司提议或实施大幅上调保费的市场,此类变化受到了媒体、州监管机构和政策制定者的极大关注。《患者保护和平价医疗法案》(PPACA)要求从2011年9月开始对保费增长进行年度审查,并披露那些确定不合理的增长。根据PPACA,每个州将对个人和小型团体的健康保险进行审查,除非联邦政府认为他们没有有效的审查计划并承担审查责任。正如他们在PPACA之前所做的那样,州法律规定了费率是否生效,并建立了监管机构权力的参数。本问题简要概述了自PPACA颁布以来,州和联邦在费率审查过程中的具体角色以及费率审查过程的变化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The Star Rating System and Medicare Advantage Plans. Telehealth: into the mainstream? Seeking value in Medicare: performance measurement for clinical professionals. Health workforce needs: projections complicated by practice and technology changes. Medicare Advantage update: benefits, enrollment, and payments after the ACA.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1